Genentech
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Genentech
May 16, 2024, 16:51 |
Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
May 12, 2024, 15:42 |
Insight
Sumanta Pal: Proud of this project on two levels
Sumanta Pal, Professor in the Department of Medical Oncology at City of Hope Medical Center,…
May 11, 2024, 00:51 |
Career
Joni Fausett: I joined Kite Pharma as the Head of US Medical Affairs
Joni Fausett, Head of US Medical Affairs at Kite Pharma, made the following post on…
May 9, 2024, 15:31 |
Blog
Hedyeh Ebrahimi: Unique challenges that community cancer centers face to engage in oncology clinical trials
Hedyeh Ebrahimi, Postdoctoral fellow at Genitourinary Cancer Research Team of City of Hope, shared a post…
May 7, 2024, 13:55 |
Blog
Karen Knudsen: Genentech reflects the depth and breadth of our commitments to improving the lives of cancer patients
Karen Knudsen shared a post by American Cancer Society on LinkedIn, adding: "Our work with…
Apr 23, 2024, 10:07 |
Insight
Ashley Magargee: Fortunate to have leading computational biology experts like Aviv Regev advancing our understanding of cancer like never before
Ashley Magargee, Chief Executive Officer at Genentech, shared on LinkedIn: "We’re fortunate to have leading…
Apr 19, 2024, 15:52 |
Drugs
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial
FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…
Apr 13, 2024, 09:17 |
Societies
30 Posts Not To Miss From AACR24!
The AACR Annual Meeting 2024 was held from April 5th to 10th in San Diego,…
Apr 10, 2024, 08:53 |
Insight
Vivek Subbiah: Cell atlas projects have contributed to our understanding of cancers
Vivek Subbiah shared on X/Twitter: "We have learned a lot from cell atlas projects -…
Feb 23, 2024, 17:26 |
Blog
Elad Sharon: Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in sarcoma!
Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, made the following post on X: "Honored…
1
2
All:
15
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube